Lostam BioPharmaceuticals
Treatment for Bacterial Infections
Health Tech & Life Sciences
Non Active, Aug 2016
Company Overview
Snapshot
Founded in October 2009 by Lewis F. Neville, PhD, Lostam BioPharmaceuticals operates with over 8,000 employees. The company is currently in the Pre-Funding stage, focusing on the research and development of novel protein therapeutics.
Business overview
Lostam BioPharmaceuticals is a Health Tech & Life Sciences company specializing in the development of a new class of protein therapeutics, or biologics. These treatments are designed to prevent and treat lethal Gram-negative bacterial infections, primarily those encountered in hospital settings. The company operates within the Pharma & Medical Biotechnology sector, with a focus on Drugs Discovery & Development and Medical Treatment & Therapeutics.
Log in to access full profile ›Company Intelligence Q&A
- What is Lostam BioPharmaceuticals' primary focus?
- Lostam BioPharmaceuticals is focused on developing novel protein therapeutics, or biologics, to prevent and treat lethal Gram-negative bacterial infections, particularly those associated with hospital environments.
- When was Lostam BioPharmaceuticals founded?
- Lostam BioPharmaceuticals was founded in October 2009.
- Who are the founders of Lostam BioPharmaceuticals?
- Lewis F. Neville, PhD is a founder of Lostam BioPharmaceuticals, serving as CEO and CTO.
- What is the current employee count for Lostam BioPharmaceuticals?
- Lostam BioPharmaceuticals currently has over 8,000 employees.
- What is Lostam BioPharmaceuticals' product development stage?
- Lostam BioPharmaceuticals is currently in the R&D stage for its product development.